What is Medical Monitoring?
Written By: Brianna Gordon
Medical monitoring, sometimes referred to as medical relief or screening, is a vital course of action that observes symptom-free individuals who have utilized high-risk pharmaceutical drugs. Medical monitoring claims are usually raised by individuals who show no signs of illness but fear contracting negative health outcomes associated with the usage of a dangerous drug.
Courts have described a claim for medical monitoring as seeking to “recover the anticipated costs of long-term diagnostic testing necessary to detect latent diseases that may develop as a result of tortious exposure to toxic substances.” Many class-action suits have called for medical monitoring of individuals who have used substances that contribute to illnesses. Complaints have been filed to seek damages for individuals who have taken dangerous drugs to ensure that users can receive medical monitoring for the rest of their lives.
Southern District of Ohio, plaintiffs formed a class-action lawsuit seeking medical monitoring compensation. Individuals who have taken drugs such as Zantac may be eligible for medical monitoring compensation to assist with the costs of diagnostic exams and medical check-ups.
As some illnesses do not reveal apparent symptoms unless checked by specialized doctors, the cost associated with this observation may be costly. Users at risk of developing negative health outcomes will have the cost of these services covered to ensure they can be regularly checked by a physician or specialist so that appropriate measures may be put in place to treat potential illnesses associated with the usage of these dangerous drugs.
These claims ensure that potential victims receive the compensation necessary to assure their health and wellbeing.
If you or a loved one have been taking Zantac and have experienced health issues or believe you are eligible for medical monitoring, contact Attorney David Rheingold immediately at 888-260-0473.
 Bowerv. Westinghouse Elec. Corp., 522 S.E.2d 424 (W. Va. 1999)